Roxane Labs ANDA suitability petitions
Executive Summary
Three additional ANDA route requests approved by FDA; one denied. Approved as ANDA suitable: furosemide oral solution 40 mg/5 ml, furosemide intensol 80 mg/ml, and propranolol HCl 20 mg/5 ml. Denied was request for diazepam intensol 10 mg/ml because the proposed concentration "is not appropriate for providing reasonable initial doses" for the elderly "or other likely populations".
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.